Literature DB >> 1500172

Contributions of complement and immunoglobulin to neutrophil-mediated killing of enterococci.

B S Harvey1, C J Baker, M S Edwards.   

Abstract

Enterococci have become a frequent causative agent in neonatal sepsis. The relative contributions of antibody and complement and their interactions in the neutrophil-mediated bacterial killing of 11 Enterococcus strains from neonates were investigated. Polymorphonuclear leukocytes (PMNL) from adult and term newborn infants were tested with normal human serum, adult hypogammaglobulinemic serum, and normal newborn serum in a neutrophil bactericidal assay. Neutrophil bactericidal activity for enterococci was not influenced by the serum source but was essentially ablated after heat inactivation of complement in all sera. No differences were observed in the killing capacity of healthy newborn versus adult PMNL regardless of serum source. Representative Enterococcus strains were then tested with agammaglobulinemic serum or C4-deficient serum, resulting in neutrophil bactericidal activities consistently exceeding 90%. A neutrophil bactericidal assay performed with normal rabbit serum and hyperimmune rabbit serum against enterococci showed that antibodies to enterococci enhanced neutrophil-mediated killing of this organism. Thus, neutrophil killing of enterococci appears to be mediated primarily by complement, with antibody playing a less essential but potentially important role. PMNL from adult and healthy term infants functioned with equal efficiency in the neutrophil killing of enterococci.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1500172      PMCID: PMC257371          DOI: 10.1128/iai.60.9.3635-3640.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

1.  Enterococcal sepsis in neonates: features by age at onset and occurrence of focal infection.

Authors:  S R Dobson; C J Baker
Journal:  Pediatrics       Date:  1990-02       Impact factor: 7.124

2.  Changes in the pattern of neonatal septicemia and meningitis.

Authors:  G H McCracken; H R Shinefield
Journal:  Am J Dis Child       Date:  1966-07

3.  The role of complement and antibody in opsonophagocytosis of type II group B streptococci.

Authors:  C J Baker; B J Webb; D L Kasper; M S Edwards
Journal:  J Infect Dis       Date:  1986-07       Impact factor: 5.226

4.  Antibody-independent classical pathway-mediated opsonophagocytosis of type Ia, group B streptococcus.

Authors:  C J Baker; M S Edwards; B J Webb; D L Kasper
Journal:  J Clin Invest       Date:  1982-02       Impact factor: 14.808

5.  Systemic group D streptococcal infection in newborn infants.

Authors:  J J Buchino; E Ciambarella; I Light
Journal:  Am J Dis Child       Date:  1979-03

6.  Variation in the group-specific carbohydrate of group A streptococci. I. Immunochemical studies on the carbohydrates of variant strains.

Authors:  M McCARTY; R C LANCEFIELD
Journal:  J Exp Med       Date:  1955-07-01       Impact factor: 14.307

7.  Abnormal mobility of neonatal polymorphonuclear leukocytes. Relationship to impaired redistribution of surface adhesion sites by chemotactic factor or colchicine.

Authors:  D C Anderson; B J Hughes; C W Smith
Journal:  J Clin Invest       Date:  1981-10       Impact factor: 14.808

8.  Streptococcus faecium outbreak in a neonatal intensive care unit.

Authors:  P E Coudron; C G Mayhall; R R Facklam; A C Spadora; V A Lamb; M R Lybrand; H P Dalton
Journal:  J Clin Microbiol       Date:  1984-12       Impact factor: 5.948

9.  Neonatal enterococcal sepsis: case-control study and description of an outbreak.

Authors:  L M Luginbuhl; H A Rotbart; R R Facklam; M H Roe; J A Elliot
Journal:  Pediatr Infect Dis J       Date:  1987-11       Impact factor: 2.129

10.  The effects of hypothermia on neutrophil function in vitro.

Authors:  V Akriotis; W D Biggar
Journal:  J Leukoc Biol       Date:  1985-01       Impact factor: 4.962

View more
  16 in total

1.  Disrupting Membrane Adaptation Restores In Vivo Efficacy of Antibiotics Against Multidrug-Resistant Enterococci and Potentiates Killing by Human Neutrophils.

Authors:  Sandra Rincon; Diana Panesso; William R Miller; Kavindra V Singh; Melissa R Cruz; Ayesha Khan; An Q Dinh; Lorena Diaz; Rafael Rios; Yousif Shamoo; Jinnethe Reyes; Truc T Tran; Danielle A Garsin; Cesar A Arias
Journal:  J Infect Dis       Date:  2019-07-02       Impact factor: 5.226

2.  Humanized mice, a new model to study the influence of drug treatment on neonatal sepsis.

Authors:  Wolfgang Ernst; Nicole Zimara; Frank Hanses; Daniela N Männel; Birgit Seelbach-Göbel; Anja K Wege
Journal:  Infect Immun       Date:  2013-02-25       Impact factor: 3.441

Review 3.  Pathogenicity of Enterococci.

Authors:  Elizabeth Fiore; Daria Van Tyne; Michael S Gilmore
Journal:  Microbiol Spectr       Date:  2019-07

4.  Naturally acquired antibodies against four Enterococcus faecalis capsular polysaccharides in healthy human sera.

Authors:  Markus Hufnagel; Andrea Kropec; Christian Theilacker; Johannes Huebner
Journal:  Clin Diagn Lab Immunol       Date:  2005-08

5.  Opportunistic bacterial infections in breeding colonies of the NSG mouse strain.

Authors:  O Foreman; A M Kavirayani; S M Griffey; R Reader; L D Shultz
Journal:  Vet Pathol       Date:  2010-09-03       Impact factor: 2.221

Review 6.  Virulence of enterococci.

Authors:  B D Jett; M M Huycke; M S Gilmore
Journal:  Clin Microbiol Rev       Date:  1994-10       Impact factor: 26.132

7.  Contribution of antibody to neutrophil-mediated killing of Enterococcus faecalis.

Authors:  M J Gaglani; C J Baker; M S Edwards
Journal:  J Clin Immunol       Date:  1997-11       Impact factor: 8.317

8.  Bactericidal activity of gentamicin against Enterococcus faecalis in vitro and in vivo.

Authors:  A Lefort; M Arthur; L Garry; C Carbon; P Courvalin; B Fantin
Journal:  Antimicrob Agents Chemother       Date:  2000-08       Impact factor: 5.191

9.  Prophylactic and therapeutic efficacy of antibodies to a capsular polysaccharide shared among vancomycin-sensitive and -resistant enterococci.

Authors:  J Huebner; A Quaas; W A Krueger; D A Goldmann; G B Pier
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

10.  Resistance of Enterococcus faecium to neutrophil-mediated phagocytosis.

Authors:  R C Arduino; K Jacques-Palaz; B E Murray; R M Rakita
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.